UTI Pharma & Healthcare Fund (G)
Fund Family UTI Mutual Fund
Fund Class Sector - Pharma & Healthcare
SNAPSHOT
Performance
Investment Info
Peers
Portfolio
News and Videos
Not Ranked
This scheme is not ranked by CRISIL.
View Top ranked funds in other categories
Returns (NAV as on May-25-2012)
| Period | Returns (%) | Rank # |
|---|---|---|
| 1 mth | -2.8 | 3 |
| 3 mth | 3.5 | 3 |
| 6 mth | 3.1 | 3 |
| 1 year | 1.5 | 3 |
| 2 year | 8.7 | 2 |
| 3 year | 23.9 | 3 |
| 5 year | 12.3 | 2 |
# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.
Absolute Returns (in %)
| Year | Qtr 1 | Qtr 2 | Qtr 3 | Qtr 4 | Annual |
|---|---|---|---|---|---|
| 2012 | 6.9 | - | - | - | - |
| 2011 | -7.8 | 6.1 | -7.2 | -0.7 | -10.0 |
| 2010 | 11.8 | 8.9 | 1.4 | 9.9 | 37.4 |
| 2009 | -1.3 | 18.2 | 25.1 | -0.2 | 65.7 |
| 2008 | -15.5 | 9.8 | -0.4 | -18.4 | -26.4 |
| 2007 | -4.4 | 13.4 | -6.5 | 10.7 | 10.8 |
* Returns over 1 year are Annualised
Performance
Fund returns v/s Category average (Sector - Pharma & Healthcare)
| 1 mth (%) | 3 mth (%) | 6 mth (%) | 1 yr (%) | 2 yr (%) | 3 yr (%) | 5yr (%) | |
| Fund Returns | -2.8 | 3.5 | 3.1 | 1.5 | 8.7 | 23.9 | 12.3 |
| Category avg | -2.3 | 5.8 | 7.2 | 5.1 | 9.8 | 27.1 | 12.9 |
| Difference of Fund returns and Category returns | -0.5 | -2.3 | -4.1 | -3.6 | -1.1 | -3.2 | -0.6 |
| Best of category | -1.4 | 7.8 | 10.3 | 10.3 | 12.7 | 31.8 | 19.9 |
| Worst of category | -2.8 | 3.5 | 3.1 | 1.5 | 7.9 | 23.9 | 6.6 |
| Benchmark returns # | -2.3 | 5.7 | 9.7 | 10.4 | 13.6 | -- | -- |
| Difference of Fund returns and Benchmark returns | -0.5 | -2.2 | -6.6 | -8.9 | -4.9 | 23.9 | 12.3 |
Investment Info
Investment Objective
Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.
Scheme details
| Fund Type | Open-Ended |
|---|---|
| Investment Plan | Growth |
| Launch date | Jun 26, 1999 |
| Benchmark | CNX Pharma |
| Asset Size (Rs cr) | 93.37 (Mar-31-2012) |
| Minimum Investment | Rs.5000 |
| Last Dividend | N.A. View Dividend History |
| Bonus | N.A. |
| Fund Manager | Lalit Nambiar View performance of schemes managed by the Fund Manager |
| Notes | N.A |
Load Details
| Entry Load | N.A |
|---|---|
| Exit Load | 1.00% |
| Load Comments | Exit Load 1% if redeemed within 1 Year from the date of allotment. |
Contact Details
| Regd. Office | UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051 |
|---|---|
| Tel. No. | 66786666 |
| Fax No. | 26524921 |
| uti@giasbm01.vsnl.net.in | |
| Website | http://www.utimf.com |
Peer Comparison
| Sector - Pharma & Healthcare | Crisil Rank | Assets (Rs.cr) |
|||||
| 3mth (%) | 6mth (%) | 1yr (%) | 3yr (%) | 5yr (%) | |||
| Reliance Pharma Fund (G) | Not Ranked |
563.56 | 6.0 | 8.1 | 3.4 | 31.8 | 19.9 |
| SBI Magnum Pharma Fund (G) | Not Ranked |
41.05 | 7.8 | 10.3 | 10.3 | 25.5 | 6.6 |
| UTI Pharma & Health (G) | Not Ranked |
93.37 | 3.5 | 3.1 | 1.5 | 23.9 | 12.3 |
| * Returns over 1 year are Annualised | More » | ||||||
Portfolio
Top Holdings (Apr 30, 12)
| Equity | Sector | Value (Rs cr) |
Asset % |
|---|---|---|---|
| Sun Pharma | Pharmaceuticals | - | 17.36 |
| Dr Reddys Labs | Pharmaceuticals | - | 17.34 |
| Lupin | Pharmaceuticals | - | 9.99 |
| Cipla | Pharmaceuticals | - | 9.73 |
| GlaxoSmithKline | Pharmaceuticals | - | 6.99 |
| Wyeth | Pharmaceuticals | - | 5.61 |
| Pfizer | Pharmaceuticals | - | 4.80 |
| Cadila Health | Pharmaceuticals | - | 4.73 |
| Divis Labs | Pharmaceuticals | - | 3.97 |
| Biocon | Pharmaceuticals | - | 3.23 |
Sector Allocation (Apr 30, 12)
| Sector | % | 1-Year HighLow |
|
|---|---|---|---|
| Pharmaceuticals | 94.72 | 95.75 | 90.53 |
Asset Allocation (%)(Apr 30, 12)
| Equity | 94.72 |
| Others | 0.00 |
| Debt | 1.33 |
| Mutual Funds | N.A |
| Money Market | 0.00 |
| Cash / Call | 3.94 |
Concentration
| Holdings | (%) |
|---|---|
| Top 5 | 61.41 |
| Top 10 | 83.75 |
| Sector | (%) |
|---|---|
| Top 3 | 94.72 |
News & Videos
News
NAVs slips led by weak global and local cues
May 15, 2012 at 9:51 | Source:
-
NAVs slumped as markets ends lower
May 12, 2012 at 11:14 | Source:
-
UTI MF wants to sack CMO to revive dipping fortunes
May 08, 2012 at 17:26 | Source:
Videos
-
Oct 25, 2011
-
Oct 25, 2011
-
Oct 25, 2011
Messages & Community
Quick Links